Thomson Reuters news
The latest findings from the Thomson Reuters Institute’s “Global Trade Report 2022” demonstrate how global trade technology is playing an increasingly important role for companies amidst a challenging regulatory environment, yet many businesses are still behind the curve in its adoption.
Over eight in ten (81%) of survey respondents said that
- Q1 EBITDA from continuing operations up 14% to € 325 million
- Life Sciences results driven by ongoing good performance in Nutrition
- Materials Sciences posts solid results reflecting volume gains and pricing strength
- EPS € 0.91, 30% higher also due to a lower tax rate
- Martek integration underway; EBITDA in line with expectations
Gouda - Imtech N.V. (technical services provider in Europe) announces that it has been awarded orders worth over 130 million euro in the care & cure sector in Germany. Innovation is the key word here. Imtech is involved in various innovations relating to ventilation, energy efficiency, ultra clean air in operating theatres and the use of medical gases.
Royal DSM N.V. (NYSE Euronext: DSM KON), the global Life Sciences and Materials Sciences company, today announces that it has successfully completed the acquisition of Martek Biosciences Corporation. The acquisition, announced on 21 December 2010, is the first major acquisition by DSM after its successful transformation into a Life Sciences and Materials Sciences company.
<
The Supervisory Board of Royal DSM is pleased to announce that it will propose to the Annual General Meeting of Shareholders on 28 April 2011 to appoint Mr. Stefan Doboczky to the Managing Board of DSM with responsibility for DSM's Pharma cluster as well as the regional responsibility of DSM's activities in Asia, with effect from 1 May 2011.
Mr. Doboczky will operate from two office locations, in the Netherlands and